Trial record 73 of 88 for: "Neuromuscular Disease" | "Norepinephrine"
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01234675|
Recruitment Status : Completed
First Posted : November 4, 2010
Results First Posted : July 22, 2015
Last Update Posted : August 21, 2019
Mansoor Ahmed M.D.
Information provided by (Responsible Party):
Mansoor Ahmed M.D., Cleveland Sleep Research Center
|Study Design||Allocation: Randomized; Intervention Model: Crossover Assignment; Masking: Double (Participant, Investigator); Primary Purpose: Treatment|
A well-established adaptation and re-adaptation to laboratory effects may have compromised our results. Other study biases include biases inherent in the crossover design, and a small sample size.